CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 154 enrolled
Drug / intervention
Nicotine Transdermal Patch +2 moredrug
Likely dose
Nicotine Transdermal Patch 14mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01145001
NCT01145001N/ACompleted
CompareCT.gov

Contingency Management for Smoking Cessation in Adolescent Smokers - Phase IV, Enhancing a High School Based Smoking Cessation Program

Yale University·interventional·Posted Jun 16, 2010·Updated Dec 29, 2016

In Brief

A clinical study evaluating Cognitive Behavioural Therapy, Contingency Management, and 1 other intervention for Nicotine Dependence. Completed, enrolled 154 participants across 1 site.

Detailed Summary

The purpose of this study is to examine the the efficacy of adjunctive nicotine replacement therapy when used in combination with the contingency management (CM) + cognitive behavioral therapy intervention. Subjects will be randomly assigned to receive either a nicotine transdermal patch or a placebo patch as well as being randomly assigned to receive either CM or no CM; all subjects will receive cognitive behavioral therapy. We hypothesize that that subjects receiving both active nicotine patch and CM will have higher rates of abstinence from tobacco than subjects in the other groups.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNicotine Dependence
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJun 16, 2010
Enrollment StartNov 1, 2009
Primary CompletionJul 1, 2014
Study CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 16.0 years ago

Interventions

Cognitive Behavioural Therapybehavioral

Weekly CBT for all subjects

Contingency Managementbehavioral

incentives given for abstinence based on urine analysis

Nicotine Transdermal Patchdrug

14mg ir 21mg doses based on weight and #cigs/day